STOCK TITAN

[Form 4] PHINIA Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 Filing Details - PHINIA Insider Trading Activity

Director Norman Daun reported the following transaction:

  • Acquired 21 shares of Common Stock on June 16, 2025
  • Acquisition price: $0 per share
  • Transaction type: Automatic dividend reinvestment on restricted stock
  • Total beneficial ownership after transaction: 19,876 shares (including 3,320 restricted shares)

The shares were acquired through automatic dividend reinvestment on existing restricted stock holdings, as required by the award terms. The transaction was reported via Form 4 filing, signed by Kate Vandenberg as attorney-in-fact for Norman on June 18, 2025.

Dettagli della Presentazione del Modulo 4 - Attività di Insider Trading di PHINIA

Il direttore Norman Daun ha segnalato la seguente transazione:

  • Acquisizione di 21 azioni di Azioni Ordinarie il 16 giugno 2025
  • Prezzo di acquisizione: $0 per azione
  • Tipo di transazione: reinvestimento automatico dei dividendi su azioni vincolate
  • Proprietà totale beneficiaria dopo la transazione: 19.876 azioni (inclusi 3.320 azioni vincolate)

Le azioni sono state acquisite tramite reinvestimento automatico dei dividendi sulle azioni vincolate esistenti, come previsto dai termini dell’assegnazione. La transazione è stata comunicata tramite la presentazione del Modulo 4, firmata da Kate Vandenberg in qualità di procuratore per Norman il 18 giugno 2025.

Detalles de la Presentación del Formulario 4 - Actividad de Operaciones Internas de PHINIA

El director Norman Daun reportó la siguiente transacción:

  • Adquirió 21 acciones de acciones ordinarias el 16 de junio de 2025
  • Precio de adquisición: $0 por acción
  • Tipo de transacción: reinversión automática de dividendos sobre acciones restringidas
  • Propiedad total beneficiaria tras la transacción: 19,876 acciones (incluyendo 3,320 acciones restringidas)

Las acciones fueron adquiridas mediante reinversión automática de dividendos sobre acciones restringidas existentes, según lo establecido en los términos de la concesión. La transacción fue reportada mediante la presentación del Formulario 4, firmado por Kate Vandenberg como apoderada de Norman el 18 de junio de 2025.

Form 4 제출 내역 - PHINIA 내부자 거래 활동

이사 Norman Daun이 다음 거래를 보고했습니다:

  • 2025년 6월 16일에 보통주 21주 취득
  • 취득 가격: 주당 $0
  • 거래 유형: 제한 주식에 대한 자동 배당 재투자
  • 거래 후 총 실질 소유 주식 수: 19,876주 (제한 주식 3,320주 포함)

해당 주식은 수여 조건에 따라 기존 제한 주식 보유분에 대한 자동 배당 재투자를 통해 취득되었습니다. 이 거래는 2025년 6월 18일 Norman을 위한 법정대리인 Kate Vandenberg가 서명한 Form 4 제출을 통해 보고되었습니다.

Détails de la Déclaration du Formulaire 4 - Activité d’Initiés PHINIA

Le directeur Norman Daun a déclaré la transaction suivante :

  • Acquisition de 21 actions ordinaires le 16 juin 2025
  • Prix d’acquisition : 0 $ par action
  • Type de transaction : réinvestissement automatique des dividendes sur actions restreintes
  • Possession bénéficiaire totale après la transaction : 19 876 actions (dont 3 320 actions restreintes)

Les actions ont été acquises via un réinvestissement automatique des dividendes sur des actions restreintes existantes, conformément aux termes de l’attribution. La transaction a été déclarée par le dépôt du Formulaire 4, signé par Kate Vandenberg en qualité de mandataire de Norman le 18 juin 2025.

Details der Formular 4 Einreichung - PHINIA Insiderhandel Aktivitäten

Direktor Norman Daun meldete die folgende Transaktion:

  • Erwerb von 21 Aktien der Stammaktien am 16. Juni 2025
  • Erwerbspreis: $0 pro Aktie
  • Transaktionstyp: Automatische Dividenden-Reinvestition bei beschränkten Aktien
  • Gesamtbegünstigtes Eigentum nach der Transaktion: 19.876 Aktien (einschließlich 3.320 beschränkter Aktien)

Die Aktien wurden durch automatische Dividenden-Reinvestition auf bestehende beschränkte Aktienbestände erworben, wie es die Zuweisungsbedingungen vorsehen. Die Transaktion wurde durch die Einreichung des Formulars 4 gemeldet, das am 18. Juni 2025 von Kate Vandenberg als Bevollmächtigte für Norman unterzeichnet wurde.

Positive
  • None.
Negative
  • None.

Dettagli della Presentazione del Modulo 4 - Attività di Insider Trading di PHINIA

Il direttore Norman Daun ha segnalato la seguente transazione:

  • Acquisizione di 21 azioni di Azioni Ordinarie il 16 giugno 2025
  • Prezzo di acquisizione: $0 per azione
  • Tipo di transazione: reinvestimento automatico dei dividendi su azioni vincolate
  • Proprietà totale beneficiaria dopo la transazione: 19.876 azioni (inclusi 3.320 azioni vincolate)

Le azioni sono state acquisite tramite reinvestimento automatico dei dividendi sulle azioni vincolate esistenti, come previsto dai termini dell’assegnazione. La transazione è stata comunicata tramite la presentazione del Modulo 4, firmata da Kate Vandenberg in qualità di procuratore per Norman il 18 giugno 2025.

Detalles de la Presentación del Formulario 4 - Actividad de Operaciones Internas de PHINIA

El director Norman Daun reportó la siguiente transacción:

  • Adquirió 21 acciones de acciones ordinarias el 16 de junio de 2025
  • Precio de adquisición: $0 por acción
  • Tipo de transacción: reinversión automática de dividendos sobre acciones restringidas
  • Propiedad total beneficiaria tras la transacción: 19,876 acciones (incluyendo 3,320 acciones restringidas)

Las acciones fueron adquiridas mediante reinversión automática de dividendos sobre acciones restringidas existentes, según lo establecido en los términos de la concesión. La transacción fue reportada mediante la presentación del Formulario 4, firmado por Kate Vandenberg como apoderada de Norman el 18 de junio de 2025.

Form 4 제출 내역 - PHINIA 내부자 거래 활동

이사 Norman Daun이 다음 거래를 보고했습니다:

  • 2025년 6월 16일에 보통주 21주 취득
  • 취득 가격: 주당 $0
  • 거래 유형: 제한 주식에 대한 자동 배당 재투자
  • 거래 후 총 실질 소유 주식 수: 19,876주 (제한 주식 3,320주 포함)

해당 주식은 수여 조건에 따라 기존 제한 주식 보유분에 대한 자동 배당 재투자를 통해 취득되었습니다. 이 거래는 2025년 6월 18일 Norman을 위한 법정대리인 Kate Vandenberg가 서명한 Form 4 제출을 통해 보고되었습니다.

Détails de la Déclaration du Formulaire 4 - Activité d’Initiés PHINIA

Le directeur Norman Daun a déclaré la transaction suivante :

  • Acquisition de 21 actions ordinaires le 16 juin 2025
  • Prix d’acquisition : 0 $ par action
  • Type de transaction : réinvestissement automatique des dividendes sur actions restreintes
  • Possession bénéficiaire totale après la transaction : 19 876 actions (dont 3 320 actions restreintes)

Les actions ont été acquises via un réinvestissement automatique des dividendes sur des actions restreintes existantes, conformément aux termes de l’attribution. La transaction a été déclarée par le dépôt du Formulaire 4, signé par Kate Vandenberg en qualité de mandataire de Norman le 18 juin 2025.

Details der Formular 4 Einreichung - PHINIA Insiderhandel Aktivitäten

Direktor Norman Daun meldete die folgende Transaktion:

  • Erwerb von 21 Aktien der Stammaktien am 16. Juni 2025
  • Erwerbspreis: $0 pro Aktie
  • Transaktionstyp: Automatische Dividenden-Reinvestition bei beschränkten Aktien
  • Gesamtbegünstigtes Eigentum nach der Transaktion: 19.876 Aktien (einschließlich 3.320 beschränkter Aktien)

Die Aktien wurden durch automatische Dividenden-Reinvestition auf bestehende beschränkte Aktienbestände erworben, wie es die Zuweisungsbedingungen vorsehen. Die Transaktion wurde durch die Einreichung des Formulars 4 gemeldet, das am 18. Juni 2025 von Kate Vandenberg als Bevollmächtigte für Norman unterzeichnet wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Norman Daun

(Last) (First) (Middle)
3000 UNIVERSITY DRIVE

(Street)
AUBURN HILLS MI 48326

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PHINIA INC. [ PHIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/16/2025 A 21(1) A $0 19,876(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects shares of restricted stock acquired following the automatic reinvestment of dividends on outstanding restricted stock held on the dividend record date, as required by the terms of such award.
2. Includes 3,320 shares of restricted stock.
Remarks:
/s/ Kate Vandenberg as attorney-in-fact for D'aun Norman 06/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many PHIN shares did Director Norman D'aun acquire on June 16, 2025?

According to the Form 4 filing, Director Norman D'aun acquired 21 shares of PHIN common stock on June 16, 2025, through dividend reinvestment on existing restricted stock holdings.

What is the total number of PHIN shares Norman D'aun owns after the June 16, 2025 transaction?

Following the reported transaction, Norman D'aun beneficially owns a total of 19,876 shares of PHIN, of which 3,320 shares are restricted stock. All shares are held directly (not indirectly through other entities).

What was the purchase price for PHIN shares acquired by Norman D'aun?

The shares were acquired at $0 per share, as they were received through automatic dividend reinvestment on existing restricted stock holdings, as required by the terms of the restricted stock award.

What is Norman D'aun's role at PHIN and what type of transaction was reported?

Norman D'aun serves as a Director at PHINIA Inc. The reported transaction was an acquisition of common stock through dividend reinvestment on restricted stock holdings, coded as transaction type 'A' in the Form 4 filing.
Phinia Inc

NYSE:PHIN

PHIN Rankings

PHIN Latest News

PHIN Latest SEC Filings

PHIN Stock Data

1.69B
38.93M
1.91%
104.93%
6.26%
Auto Parts
Motor Vehicle Parts & Accessories
Link
United States
AUBURN HILLS